The preclinical discovery of bacterial therapy for the treatment of metastatic cancer with unique advantages

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.7, Iss.1, 2012-02, pp. : 73-83

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preclinical discovery of duloxetine for the treatment of depression

By Torres-Sanchez Sonia Perez-Caballero Laura Mico Juan Antonio Elorza Julian Berrocoso Esther

Expert Opinion on Drug Discovery, Vol. 7, Iss. 8, 2012-08 ,pp. : 745-755

Informa Healthcare

Access to resources Recommend Favorite

The preclinical discovery and development of ezogabine for the treatment of epilepsy

By Jankovic Slobodan Ilickovic Ivana

Expert Opinion on Drug Discovery, Vol. 8, Iss. 11, 2013-11 ,pp. : 1429-1437

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Metastatic Pancreatic Cancer

By Ko Andrew H. Tempero Margaret A.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 3, Iss. 5, 2005-09 ,pp. : 627-636

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Panitumumab: In the Treatment of Metastatic Colorectal Cancer

By Hoy Sheridan M. Wagstaff Antona J.

Drugs, Vol. 66, Iss. 15, 2006-01 ,pp. : 2005-2014

Adis International

Access to resources Recommend Favorite

Cetuximab: In the Treatment of Metastatic Colorectal Cancer

By Reynolds N.A. Wagstaff A.J.

Drugs, Vol. 64, Iss. 1, 2004-01 ,pp. : 109-118

Adis International

Access to resources Recommend Favorite